智醫科學

智醫科學

「智醫科學」提供即時的人工智慧醫療行業內容,以專業科學角度提供全球人工智慧醫療領域最新產業動態與技術焦點。

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe 03/06/2024

【臨床試驗】《Massive Bio》與《Mika Health》合作為癌症患者提供臨床試驗配對
#臨床試驗 #癌症

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe ASCO Annual Meeting – Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platfor

Tempus Announces the Clinical Launch of its MRD Testing Portfolio 02/06/2024

【癌症】AI精準醫療《Tempus》推出「微量殘存疾病(MRD)」檢測產品,幫助監測早期癌症復發與免疫療法的治療反應
#癌症 #精準醫療 #癌症復發 #免疫療法

Tempus Announces the Clinical Launch of its MRD Testing Portfolio Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test por

Jivi's Medical LLM Beats OpenAI at the Open Medical LLM Leaderboard 02/06/2024

【LLM】《Jivi》醫學LLM擊敗GPT-4和Med-PaLM 2,平均得分為91.65

Jivi's Medical LLM Beats OpenAI at the Open Medical LLM Leaderboard A purpose-built medical Large Language Model (LLM) developed by Jivi, an Indian healthcare AI startup co-founded by former BharatPe Chief Product Officer Ankur Jain and GV Sanjay Reddy, Chairman, Reddy Ventures, has ranked number 1 on the Open Medical LLM Leaderboard.

Eight Sleep Appoints Dr. Andrew Huberman, Dr. Matthew Walker, and Dr. Peter Attia to Its Scientific Advisory Board 02/06/2024

【睡眠】《Eight Sleep》將強化數據驅動方法,建立「睡眠」新標準
#睡眠

Eight Sleep Appoints Dr. Andrew Huberman, Dr. Matthew Walker, and Dr. Peter Attia to Its Scientific Advisory Board Eight Sleep, the world’s first sleep fitness company, announces the additions of Dr. Andrew Huberman, Dr. Matthew Walker, and Dr. Peter Attia to its S

ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology 02/06/2024

【蛋白質】《ExpressionEdits》獲得1,300萬美元種子輪資金,將透過改善蛋白質表現來開發新型基因藥物
#募資 #蛋白質 #基因

ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology

Plenful Secures $17M Series A to Streamline Pharmacy Operations with AI-Powered Workflow Automation 02/06/2024

【藥局】AI藥局新創《Plenful》獲得1,700萬美元A輪融資

#募資 #藥局

Plenful Secures $17M Series A to Streamline Pharmacy Operations with AI-Powered Workflow Automation Plenful, an AI workflow automation platform streamlining pharmacy and healthcare operations, today announced a $17M Series A round, increasing its tot

ICF helps FDA accelerate the drug labeling review process with AWS machine learning | Amazon Web Services 02/06/2024

【標籤】《ICF》透過《AWS》機器學習幫助FDA加速「藥劑製品標籤」審查流程

#藥品標籤 #標籤

ICF helps FDA accelerate the drug labeling review process with AWS machine learning | Amazon Web Services Within the Food and Drug Administration's Center for Drug Evaluation and Research, the Division of Medication Error Prevention and Analysis (DMEPA) plays a critical role. DMEPA reviews premarket and postmarket drug labeling to minimize the risk of medication errors. In partnership with DMEPA, Amazon...

Indica Labs Announces AI-Powered HALO® Software Release for Digital Pathology Research in Life Sciences 02/06/2024

【病理】《Indica Labs》推出數位病理生態系統的人工智慧影像分析
#數位病理

Indica Labs Announces AI-Powered HALO® Software Release for Digital Pathology Research in Life Sciences Albuquerque, NM – 23 May 2024 - Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry-leading life sciences software.

Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs 02/06/2024

【標靶】《Cartography》與《Gilead》合作開發三陰性乳癌和肺腺癌的新標靶療法
#乳癌 #肺腺癌 #標靶

Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs Cartography Biosciences, Inc., announced today that it has entered into a strategic collaboration agreement with Gilead Sciences, Inc., to discover an

Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome 02/06/2024

【老化】藥物發現《Integrated Bio》加入《Illumina Ventures Labs》設計老化和發育相關疾病的新型療法
#老化 #發育 #藥物發現

Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics f

Redox, Snowflake Partner to Streamline Healthcare Data Exchange for AI and Machine Learning 26/05/2024

【醫療資料】《Redox》與《Snowflake》合作簡化醫療資料交換

#醫療資料 #資料交換

Redox, Snowflake Partner to Streamline Healthcare Data Exchange for AI and Machine Learning Redox, a healthcare interoperability company, and Snowflake have joined forces to simplify the exchange of healthcare data for AI/ML

Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery 26/05/2024

【心理健康】《Ontrak: OTRK》推出心理健康數位分身(MHDT)技術

#心理健康 #數位分身

Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery Ontrak Inc (NASDAQ: OTRK), a leading AI-powered and technology-enabled healthcare company, today announced the launch of its pioneering Mental Health

A-Alpha Bio lands $14.5M from Department of Defense to prep for future biological threats 26/05/2024

【抗體】《A-Alpha Bio》獲美國國防部1,450萬美元,透過高通量抗體-抗原平台發現新抗體

#抗體 #抗原

A-Alpha Bio lands $14.5M from Department of Defense to prep for future biological threats A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine learning tools.

Loughborough partnership will create new app to transform self-management of chronic health conditions 26/05/2024

【慢性病】「Holly Health Prevent」: 管理多種慢性病的App

#慢性病

Loughborough partnership will create new app to transform self-management of chronic health conditions Researchers from Loughborough’s Centre for Lifestyle Medicine and Behaviour (CLiMB) and Wolfson School of Engineering are set to develop an innovative digital health app, that will help individuals with multiple chronic conditions to manage their health care better.

Leumit Health Services Expands Partnership with FeelBetter to Optimize Polypharmacy Patient Management and Drive Value-Based Care in Israel 23/05/2024

【用藥】 「Leumit Health」與「FeelBetter」合作優化多重藥物患者管理

#多重藥物 #用藥安全

Leumit Health Services Expands Partnership with FeelBetter to Optimize Polypharmacy Patient Management and Drive Value-Based Care in Israel FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced that it

John Snow Labs Achieves New State-of-the-Art Medical LLM Accuracy Benchmarks Outperforming GPT-4, Med-PaLM2, and Hundreds of Others 23/05/2024

【LLM】 「JSL-MedLX-7B」在PubMedQA測試擊敗GPT-4

John Snow Labs Achieves New State-of-the-Art Medical LLM Accuracy Benchmarks Outperforming GPT-4, Med-PaLM2, and Hundreds of Others John Snow Labs achieves new state-of-the-art medical LLM accuracy on benchmarks used in the Open Medical LLM leaderboard, surpassing hundreds of others....

AI Sleep Tech Innovator Honored With Industry Contributor Prize 23/05/2024

【睡眠】即時睡眠障礙分析「SOMNUM」獲FDA 510(k)許可

#睡眠 #睡眠障礙

AI Sleep Tech Innovator Honored With Industry Contributor Prize The awardee developed an AI-powered algorithm for real-time sleep disorder analysis, which recently received FDA 510(k) clearance.

Drug discovery biotech LabGenius raises a £35m Series B 23/05/2024

【癌症】癌症抗體療法新創《LabGenius》完成3,500萬英鎊B輪融資,由Merck風投M Ventures領投
#募資 #癌症 #抗體

Drug discovery biotech LabGenius raises a £35m Series B LabGenuis' robotics platform is using machine learning to create new molecules to tackle cancer. Its total funding stands at £58m.

Phastar links up with Beaconcure to improve clinical review processes 23/05/2024

【臨床】生物辨識CRO《Phastar》導入《Beaconcure》機器學習,加速臨床審查流程

#臨床

Phastar links up with Beaconcure to improve clinical review processes Biometrics contract research organization Phastar is integrating technology from Beaconcure, a trial data analytics software provider, into clients’ trial operations, according to a May 20

DentalMonitoring Sets New Standard In Orthodontic Remote Monitoring With De Novo Approval By the U.S. Food and Drug Administration (FDA). 21/05/2024

【牙科】遠端牙科監測「DentalMonitoring」獲FDA De Novo批准

#牙科 #遠距

DentalMonitoring Sets New Standard In Orthodontic Remote Monitoring With De Novo Approval By the U.S. Food and Drug Administration (FDA). DentalMonitoring receives FDA De Novo approval for AI-powered orthodontic remote monitoring for improved patient care and communication.

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias 21/05/2024

【心房撲動】《HeartBeam AI》結合心電向量圖,在檢測「心房撲動」優於心臟科醫生

#心房撲動 #心電向量圖

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

AI Agents Healthcare: A Nvidia And Hippocratic AI Partnership 20/05/2024

【藥物】Nvidia和《Hippocratic AI》合作解決醫療保健人員短缺問題並改善病患治療結果
#人員短缺

AI Agents Healthcare: A Nvidia And Hippocratic AI Partnership Nvidia and Hippocratic AI develop advanced AI agents that outperform human nurses on video calls, offering cost-effective and empathetic healthcare solutions.

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development 20/05/2024

【細胞】《Accenture: ACN》投資《Turbine》以加速AI驅動的細胞模擬在生物製藥研發之應用
#上市動態 #細胞

Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development Accenture has made a strategic investment, through Accenture Ventures, in Turbine.

16/05/2024

【ALS】神經退化《NeuroSense: NRSN》宣布與《PhaseV》合作PrimeC 治療「肌萎縮性側索硬化症(ALS)」3期臨床

#臨床 #肌萎縮性側索硬化症 #漸凍症

NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine Learning | BioSpace NeuroSense Therapeutics announced that it partnered with PhaseV, a pioneer in causal machine learning for clinical trial analysis and optimization, with respect to the planned Phase 3 trial of PrimeC as a treatment for amyotrophic lateral sclerosis.

HHS CREATE explores new approach to AI machine learning - Hamilton Health Sciences 16/05/2024

【血液】《HHS CREATE》使用AI準確監測「warfarin」劑量
#血液 #劑量 #心臟病

HHS CREATE explores new approach to AI machine learning - Hamilton Health Sciences If you know someone with diabetes, you may have noticed them wearing an insulin pump. It may even be a...

Iambic Therapeutics Selects Lambda Cloud to Help Meet Compute Demands of its Generative AI Drug Discovery Models 15/05/2024

【蛋白質】《Lambda》與生成式AI藥物發現《Iambic》合作開發新型療法
#藥物發現 #蛋白質

Iambic Therapeutics Selects Lambda Cloud to Help Meet Compute Demands of its Generative AI Drug Discovery Models Lambda, the GPU cloud company founded by AI engineers and powered by NVIDIA GPUs, today announced that Iambic Therapeutics, a clinical-stage biotechno

Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design 15/05/2024

【蛋白質】蛋白質藥物發現《Nabla》完成2,600萬美元A輪,由Radical Ventures領投

#藥物發現 #蛋白質 #募資

Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design

Komodo Grows Its MapEnhance Offering, Expanding Access to New Social Determinants of Health Insights Alongside Real-World Oncology Data and Rare Disease Genomics 15/05/2024

【精準醫療】患者旅程「MapEnhance」導入「健康社會決定因素(SDOH)」分析功能
#精準醫療

Komodo Grows Its MapEnhance Offering, Expanding Access to New Social Determinants of Health Insights Alongside Real-World Oncology Data and Rare Disease Genomics Today, Komodo Health announced a series of updates to its MapEnhanceTM offering, increasing the depth and volume of insights into social determinants

CLEW Medical Secures FDA Clearance for Second-Generation AI Models 15/05/2024

【病情】臨床監測《CLEW》第二代預測「病情惡化」AI獲得FDA 510(k)批准
#臨床監測 #病情惡化

CLEW Medical Secures FDA Clearance for Second-Generation AI Models CLEW Medical, a clinical surveillance and predictive analytics company, today announced that its second-generation, AI/machine-learning models for pre

The Association of Cancer Care Centers and Flatiron Health Announce a Strategic Collaboration to Improve Study Data Capture 15/05/2024

【癌症】《Flatiron Health》與《ACCC》合作癌症臨床試驗資料收集
#癌症 #臨床試驗

The Association of Cancer Care Centers and Flatiron Health Announce a Strategic Collaboration to Improve Study Data Capture Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology and closing the gap betw